Earnings History Data for Johnson & Johnson (JNJ) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Johnson & Johnson

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
16-04-2024 PM JNJ Johnson & Johnson 355,340 2.71 2.64 2.68 JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results
[4/15/2024 1:49 PM]
144.93 -2.66 
(-1.81%)
145.09 -2.50 
(-1.69%)
143.39 - 175.97 9,576,037 7,080,000 113,579
23-01-2024 PM JNJ Johnson & Johnson 388,080 2.29 2.27 2.35 Johnson & Johnson beats top and bottom line estimates; reaffirms FY24 outlook
[1/23/2024 6:24 AM]
159.84 -2.62 
(-1.62%)
159.28 -3.19 
(-1.96%)
144.95 - 175.97 7,706,969 5,860,000 64,861
17-10-2023 PM JNJ Johnson & Johnson 406,300 2.66 2.52 2.55 Johnson & Johnson Non-GAAP EPS of $2.66 beats by $0.14, revenue of $21.35B beats by $300M
[10/17/2023 6:21 AM]
155.82 -1.71 
(-1.08%)
156.24 -1.29 
(-0.82%)
150.11 - 181.04 10,111,016 5,670,000 211,779
20-07-2023 PM JNJ Johnson & Johnson 413,380 2.80 2.61 2.59 Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M
[7/20/2023 6:25 AM]
168.23 9.49 
(5.98%)
161.55 2.81 
(1.77%)
150.11 - 181.04 19,052,079 6,370,000 360,290
18-04-2023 PM 6:25 AM ET
(Apr 18)
JNJ Johnson & Johnson 517,390 2.68 2.51 2.67 Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance
[4/18/2023 6:22 AM]
161.03 -4.63 
(-2.80%)
165.34 -0.33 
(-0.20%)
150.11 - 186.69 12,512,529 7,940,000 272,774
24-01-2023 PM 6:25 AM ET
(Jan 24)
JNJ Johnson & Johnson 441,170 2.35 2.22 2.13 Johnson & Johnson Non-GAAP EPS of $2.35 beats by $0.11, revenue of $23.7B misses by $200M
[1/24/2023 6:26 AM]
168.32 0.01 
(0.01%)
167.40 -0.91 
(-0.54%)
155.72 - 186.69 8,756,017 6,690,000 373,322
18-10-2022 PM 6:25 AM ET
(Oct 18)
JNJ Johnson & Johnson 434,209 2.55 2.49 0.00 Johnson & Johnson Non-GAAP EPS of $2.55 beats by $0.06, revenue of $23.8B beats by $360M
[10/18/2022 6:27 AM]
165.95 -0.64 
(-0.38%)
165.00 -1.59 
(-0.95%)
155.72 - 186.69 8,365,384 5,780,000 362,576
19-07-2022 PM 6:25 AM ET
(Jul 19)
JNJ Johnson & Johnson 468,990 2.59 2.57 2.48 Johnson & Johnson Non-GAAP EPS of $2.59 beats by $0.04, revenue of $24B beats by $180M, cuts FY22 guidance
[7/19/2022 6:26 AM]
171.72 -2.50 
(-1.44%)
175.60 1.37 
(0.79%)
155.72 - 186.69 11,057,411 5,290,000 98,020
19-04-2022 PM 6:25 AM ET
(Apr 19)
JNJ Johnson & Johnson 475,070 2.67 2.61 2.59 Johnson & Johnson Non-GAAP EPS of $2.67 beats by $0.10, revenue of $23.4B misses by $210M, reaffirms guidance
[4/19/2022 6:26 AM]
182.98 5.32 
(2.99%)
179.90 2.24 
(1.26%)
155.72 - 185.94 11,665,543 6,920,000 244,699
25-01-2022 PM 6:25 AM ET
(Jan 25)
JNJ Johnson & Johnson 434,040 2.13 2.12 1.86 Johnson & Johnson Non-GAAP EPS of $2.13 beats by $0.01, revenue of $24.8B misses by $490M
[1/25/2022 6:31 AM]
167.74 4.77 
(2.93%)
162.97 0.0 
(0.00%)
151.47 - 179.92 10,220,240 8,060,000 55,222
19-10-2021 PM 6:25 AM ET
(Oct 19)
JNJ Johnson & Johnson 421,490 2.60 2.37 2.20 Johnson & Johnson EPS beats by $0.25, misses on revenue, boost FY21 guidance
[10/19/2021 6:29 AM]
163.88 3.76 
(2.35%)
160.93 0.81 
(0.51%)
133.65 - 179.92 8,707,323 5,870,000 257,758
21-07-2021 PM 6:30 AM ET
(Jul 21)
JNJ Johnson & Johnson 439,460 2.48 2.28 1.67 Johnson & Johnson EPS beats by $0.19, beats on revenue
[7/21/2021 6:31 AM]
169.46 1.02 
(0.60%)
169.00 0.55 
(0.33%)
133.65 - 173.65 6,060,319 6,750,000 57,777
20-04-2021 PM 6:40 AM ET
(Apr 20)
JNJ Johnson & Johnson 427,130 2.59 2.31 2.30 Johnson & Johnson EPS beats by $0.24, beats on revenue
[4/20/2021 6:31 AM]
166.53 3.84 
(2.36%)
161.30 -1.39 
(-0.85%)
133.65 - 173.65 11,906,795 7,920,000 51,427
26-01-2021 PM 6:40 AM ET
(Jan 26)
JNJ Johnson & Johnson 430,550 1.86 1.81 1.88 Johnson & Johnson EPS beats by $0.03, beats on revenue, guides FY21 above consensus
[1/26/2021 6:44 AM]
170.39 3.72 
(2.66%)
169.75 3.77 
(2.27%)
109.16 - 173.65 12,405,068 7,905,767 413,569
13-10-2020 PM 6:40 AM ET
(Oct 13)
JNJ Johnson & Johnson 397,480 2.20 1.98 2.12 Johnson & Johnson beats on earning, raises FY20 guidance
[10/13/2020 6:41 AM]
148.56 -3.28 
(-2.16%)
149.35 -2.49 
(-1.64%)
109.16 - 157.00 9,273,268 5,965,703 270,334
16-07-2020 PM 6:30 AM ET
(Jul 16)
JNJ Johnson & Johnson 389,970 1.67 1.49 2.58 Johnson & Johnson EPS beats by $0.16, beats on revenue
[7/16/2020 6:42 AM]
148.00 -0.26 
(-0.18%)
148.67 0.41 
(0.28%)
109.16 - 157.00 4,442,691 6,229,663 148,742